Consideration of existing data regarding clinical and biochemical risk factors for the development of breast cancer leads to the hypothesis that enhanced insulin-like growth factor I (IGF-I) activity plays a significant role in the development of this disease. Abnormal IGF-l activity may be related
A cross-sectional investigation of breast density and insulin-like growth factor I
✍ Scribed by Gertraud Maskarinec; Andrew E. Williams; Rudolph Kaaks
- Book ID
- 102273550
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- French
- Weight
- 87 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Our study investigated the association of breast cancer risk as assessed by mammographic density with insulin‐like growth factor I (IGF‐I) and one of its binding proteins (IGFBP‐3) in healthy premenopausal women with different ethnic backgrounds. In a cross‐sectional design, we analyzed the baseline mammograms and fasting serum samples (collected 5 days after ovulation) of premenopausal women entering a nutritional intervention. Serum concentrations of IGF‐I and IGFBP‐3 were measured by double‐antibody ELISA. Mammographic densities were assessed using a computer‐assisted method. We calculated Spearman correlation coefficients between mammographic characteristics and analytes and estimated means of mammographic characteristics by quartiles of IGF‐I and IGFBP‐3 while adjusting for age, body mass index (BMI) and reproductive factors. In this group of 240 women, IGF‐I, IGFBP‐3 and percent densities did not differ significantly by ethnicity. Whereas mammographic densities were not associated with IGF‐I, we found an inverse relation with IGFBP‐3 (r~s~ = ‐0.15, p = 0.02) and a positive association with the IGF‐I/IGFBP‐3 ratio (r~s~ = 0.13, p = 0.04). The size of the dense areas was not associated with the analytes, but the size of the nondense areas was correlated directly with IGFBP‐3 (r~s~ = 0.20, p = 0.002) and inversely with the molar ratio (r~s~ = −0.19, p = 0.004). These associations were limited to women with a BMI of less than 25 kg/m^2^. These results suggest that the balance of circulating IGF‐I and IGFBP‐3 levels may influence the growth of the fatty part of the breast more than the epithelial and stromal breast tissue, but the exact mechanism of action needs to be explored in more detail. © 2003 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Insulin-like growth factor-I (IGF-I) has mitogenic and antiapoptotic effects on breast cancer cells. Epidemiologic studies have shown that high plasma levels of IGF-I and low levels of IGF binding protein (BP)-3 are associated with increased risk of breast cancer in premenopausal women. The actions